Novocure Ltd Ord Sh (NVCR)

$16.80 0.55 (3.17%)

16:00 EDT NVCR Stock Quote Delayed 30 Minutes

Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025

By Alex Sirois, InvestorPlace Contributor May 14, 2024

These stocks to buy are expected to double by 2025 and could turn mundane market returns into something bigger with a willingness to bet.

NVCR Stock Earnings: NovoCure Beats EPS, Beats Revenue for Q1 2024

7 Nasdaq Stocks Down 59% Set to Soar at Least 141%

Novocure Layoffs 2023: What to Know About the Latest NVCR Job Cuts

Volume:

Previous Close -

Market Cap 1.74B

PE Ratio -9.33

EPS -1.8

Volume (Avg. Vol.) 1.28M

Day's Range $16.62 - $17.49

52-Week Range $10.87 - $42.69

Dividend & Yield N/A (N/A)

NVCR Stock Predictions, Articles, and Novocure Ltd Ord Sh News

3 Healthcare Stocks to Sell in September Before They Crash & Burn

By Noah Bolton, InvestorPlace Contributor Sep 6, 2023

The healthcare industry comprises multiple sectors, including biotechnology, pharmaceuticals, and healthcare equipment, each offering a unique and potentially risky opportunity. News regarding FDA approval and…

Why Is Novocure (NVCR) Stock Down 30% Today?

By Josh Enomoto, InvestorPlace Contributor Aug 28, 2023

Following Novocure’s disappointing late-stage clinical trial for its cancer-treating platform, NVCR stock stumbled on relevancy concerns.

3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon

By John Blankenhorn, InvestorPlace Contributor Jun 12, 2023

These three small companies could become gold or lead depending on the outcomes of their clinical trials making them top drug stocks to watch.

The 3 Most Promising Healthcare Tech Stocks for April 2023

By Alex Sirois, InvestorPlace Contributor Apr 26, 2023

The best healthcare tech stocks provide investors with impressive upside potential, while promising to improve the healthcare sector.

NovoCure (NVCR) Stock Soars 50% on Positive Clinical Trial Results

By David Moadel, InvestorPlace Contributor Jan 5, 2023

NVCR stock traders are undeniably pleased to see NovoCure marking a milestone in the company's quest to treat a specific type of lung cancer.

7 Pharmaceutical Stocks That Could Make You Rich

By Tezcan Gecgil, InvestorPlace Contributor Jan 6, 2022

These seven pharmaceutical stocks could create lucrative opportunities in the new year

NVCR Stock: The Cancer Therapy News That Has Novocure Shares Skyrocketing Today

By Nick Clarkson, Web Editor Apr 13, 2021

NVCR stock is skyrocketing on Tuesday after cancer treatment firm Novocure received great news regarding its phase 3 tumor treatment trial.

10 Stocks to Sell in Market-Cursed September

By Will Ashworth, InvestorPlace Contributor Sep 9, 2019

August was a terrible time for stocks. September could be even worse. Here are 10 stocks to sell in the days ahead.

3 Medical Devices Stocks to Buy

By Dana Blankenhorn, InvestorPlace Contributor Oct 2, 2018

When considering medical devices stocks to buy, consider companies with FDA-approved devices, growing sales and overall financial strength.

5 Medical Device Stocks With Impressive Staying Power

By Aaron Levitt, InvestorPlace Contributor Sep 13, 2018

Medical device stocks could be the best play in all of healthcare. Here are five of the best choices for any portfolio.

Trade of the Day: Novocure Ltd (NVCR)

By Ken Trester Jul 6, 2018

Biotech firms have been showing strength relative to the rest of the market lately and look like they could be bullish candidates going forward.

3 Pharma Stocks That Will Inject New Life Into Your Portfolio

By Marie Brodbeck, InvestorPlace Contributor Aug 1, 2017

These three pharma stocks all have the potential to deliver fantastic gains despite the industry’s turmoil.

Why Novocure Ltd (NVCR) Stock Just Popped 50%

By Robert Martin, InvestorPlace Writer Apr 3, 2017

Novocure's (NVCR) brain cancer treatment Optune reported strong Phase 3 trial data. As a result, NVCR stock is popping to 8-month highs.

11 Health Care Equipment & Supplies Stocks to Sell Now

By Portfolio Grader Dec 26, 2016

This week, the ratings of 11 Health Care Equipment & Supplies stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

21 Health Care Equipment & Supplies Stocks to Sell Now

By Portfolio Grader Nov 14, 2016

This week, the overall grades of 21 Health Care Equipment & Supplies stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Health Care Equipment & Supplies Stocks to Sell Now

By Portfolio Grader Oct 24, 2016

This week, the ratings of 7 Health Care Equipment & Supplies stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Healthcare Stocks That Are Investor Poison

By Louis Navellier, Editor, Growth Investor Oct 21, 2016

You can't blindly buy stocks in healthcare because there are some that have some serious problems.

Novocure Ltd Ord Sh (NVCR)

Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025

NVCR Stock Earnings: NovoCure Beats EPS, Beats Revenue for Q1 2024

7 Nasdaq Stocks Down 59% Set to Soar at Least 141%

Novocure Layoffs 2023: What to Know About the Latest NVCR Job Cuts

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novocure Ltd Ord Sh (NVCR)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NVCR Stock Predictions, Articles, and Novocure Ltd Ord Sh News

Subscriber Sign in